Contact Person : Andrew Gibbons; Last Date for the submission of abstract : Not Available ; Description : developments of novel vaccines and adjuvants for immunotherapy, along with a strong focus on allergy clinical trials and pharmacovigilance to gain a solid understanding of the current requirements and obligations in the development of immunotherapy